List of works by Selma Ugurel

A case of cutaneous Rosai-Dorfman disease refractory to imatinib therapy.

scientific article

A first prospective population-based analysis investigating the actual practice of melanoma diagnosis, treatment and follow-up

scientific article published on 24 May 2011

Absence of classical MAP kinase pathway signalling in Merkel cell carcinoma

scientific article published on May 2006

Aktuelle Therapiestudien beim Merkelzellkarzinom

scientific article published on 01 November 2018

Altered surface expression patterns of circulating monocytes in cancer patients: impaired capacity of T-cell stimulation?

scientific article

B-RAF and N-RAS mutations are preserved during short time in vitro propagation and differentially impact prognosis

scientific article

BRAFV600E mutations in malignant melanoma are associated with increased expressions of BAALC.

scientific article

Checkpoint inhibitors in chronic kidney failure and an organ transplant recipient.

scientific article published on 7 September 2016

Chemosensitivity testing in malignant melanoma.

scientific article published in January 2003

Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma: a multicenter randomized phase-3 DeCOG trial

scientific article published on 27 June 2017

Combined treatment with pegylated interferon-alpha-2a and dacarbazine in patients with advanced metastatic melanoma: a phase 2 study

scientific article published in September 2008

Comparable expression and phosphorylation of the retinoblastoma protein in Merkel cell polyoma virus-positive and negative Merkel cell carcinoma

scientific article published in February 2010

Cutaneous side effects of combined therapy with sorafenib and pegylated interferon alpha-2b in metastatic melanoma (phase II DeCOG trial).

scientific article

Cutaneous side effects of new antitumor drugs: clinical features and management

scientific article published on 24 February 2012

Dacarbazine in melanoma: from a chemotherapeutic drug to an immunomodulating agent

scientific article published in February 2013

Denileukin diftitox plus total skin electron beam radiation in patients with treatment-refractory cutaneous T-cell Lymphoma (mycosis fungoides): report of four cases

scientific article published in January 2014

Differences in global gene expression in melanoma cell lines with and without homozygous deletion of the CDKN2A locus genes.

scientific article

Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B.

scientific article

Distribution of TERT promoter mutations in primary and metastatic melanomas in Austrian patients

scientific article

ERCC5 p.Asp1104His and ERCC2 p.Lys751Gln Polymorphisms Are Independent Prognostic Factors for the Clinical Course of Melanoma

Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines

scientific article

Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe

scientific article published on 13 July 2017

Final results of phase III SYMMETRY study: randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma

scientific article

Fulminant response to combined checkpoint inhibition with ipilimumab plus nivolumab after failure of nivolumab monotherapy in metastatic melanoma

HLA-B8 association with late-stage melanoma--an immunological lesson?

scientific article

Imatinib as a treatment option for systemic non-Langerhans cell histiocytoses.

scientific article published in June 2007

Imatinib in Dermatofibrosarcoma: Targeted Therapy or Immunotherapy?

scientific article published in February 2017

Immunogenicity of constitutively active V599EBRaf

scientific article

Impact of the CCR5 gene polymorphism on the survival of metastatic melanoma patients receiving immunotherapy

scientific article published on 2 October 2007

In vitro drug sensitivity predicts response and survival after individualized sensitivity-directed chemotherapy in metastatic melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group.

scientific article published in September 2006

In vitro drug sensitivity profiling in melanoma

scientific article published in July 2008

Jo-1 positive paraneoplastic systemic sclerosis in a patient with metastatic melanoma.

scientific article published in July 2006

MC polyomavirus is frequently present in Merkel cell carcinoma of European patients.

scientific article

Management of side effects of immune checkpoint blockade by anti-CTLA-4 and anti-PD-1 antibodies in metastatic melanoma

scientific article

Melanoma-reactive T cells in the bone marrow of melanoma patients: association with disease stage and disease duration.

scientific article

Merkel cell carcinoma: molecular pathogenesis, clinical features and therapy

scientific article published on September 2008

Merkel cell carcinoma: recent insights and new treatment options

scientific article

Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature

scientific article published on August 2006

Mouse models for melanoma: a personal perspective

scientific article published on 22 October 2009

Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanoma

scientific article published in August 2008

Multiple Melanomas After Treatment for Hodgkin Lymphoma in a Non-Dutch p16-Leiden Mutation Carrier With 2 MC1R High-Risk Variants

Nebenwirkungsmanagement bei Immun-Checkpoint-Blockade durch CTLA-4- und PD1-Antikörper beim metastasierten Melanom

Neoadjuvant imatinib in advanced primary or locally recurrent dermatofibrosarcoma protuberans: a multicenter phase II DeCOG trial with long-term follow-up

scientific article

Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy.

scientific article published on 12 April 2016

New developments in biomarkers for melanoma

scientific article published on March 2013

New promises in the adjuvant, and palliative treatment of melanoma.

scientific article published on January 2007

Non-reproducible sequence artifacts in FFPE tissue: an experience report

scientific article

PD-L1 status does not predict the outcome of BRAF inhibitor therapy in metastatic melanoma

scientific article

Partial response of metastatic mucosal melanoma after palliative chemotherapy with trofosfamide: a case report

scientific article published on 3 December 2012

Presence of human polyomavirus 6 in mutation-specific BRAF inhibitor-induced epithelial proliferations

scientific article

Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity

scientific article published on 16 February 2017

Re: Association Between Endothelin Receptor B Nonsynonymous Variants and Melanoma Risk

article published in 2006

SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanoma

scientific article published on 20 January 2016

STAT3 Single Nucleotide Polymorphism rs4796793 SNP Does Not Correlate with Response to Adjuvant IFNα Therapy in Stage III Melanoma Patients

scientific article

Serologic and immunohistochemical prognostic biomarkers of cutaneous malignancies

scientific article published on March 2007

Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling

scientific article

Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients

scientific article

Skin cancer: follow-up, rehabilitation, palliative and supportive care

scientific article published on June 2008

Skin toxicity of anti-cancer therapy

scientific article

Strategies to optimize the use of targeted agents for tumor therapy

scientific article published on 17 January 2008

Survival of patients with advanced metastatic melanoma: The impact of novel therapies

scientific article published on 17 December 2015

Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017.

scientific article

Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma

scientific article

Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutations

scientific article published on 24 March 2017

The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma

scientific article

The safety and efficacy of dabrafenib and trametinib for the treatment of melanoma

scientific article published on 20 October 2017

Therapy of metastasized Merkel cell carcinoma with liposomal doxorubicin in combination with radiotherapy

scientific article published in June 2009

Treosulfan and gemcitabine in metastatic uveal melanoma patients: results of a multicenter feasibility study

scientific article

Tumor biomarkers in melanoma

scientific article published on July 2009

Tumor type M2 pyruvate kinase (TuM2-PK) as a novel plasma tumor marker in melanoma

scientific article

Uncovering first molecular mechanisms of secondary resistance against PD-1 blockade

scientific article published on December 2016

Update on the clinical use of kinase inhibitors in melanoma

scientific article published in September 2017

Upstream mitogen-activated protein kinase (MAPK) pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients

scientific article published on 29 October 2013

Vemurafenib-induced granuloma annulare.

scientific article published in March 2016

[New therapeutic approaches for solid tumors: histone deacetylase, methyltransferase and proteasome inhibitors].

scientific article

Paulina is supported by:

About Paulina

Help